Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

Mira Mousa; Mohammed Albreiki; Fatima Alshehhi; Safiya AlShamsi; Nada Al Marzouqi; Tayba Alawadi; Hussain Alrand; Habiba Alsafar; Asma Fikri

doi:10.1093/jtm/taac036

Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

University of Oxford
Ministry of Health, United Arab Emirates
Emirates Health Services
Ministry of Interior

Research output: Contribution to journal › Letter › peer-review

26 Scopus citations

Original language	English
Article number	taac036
Journal	Journal of Travel Medicine
Volume	29
Issue number	6
DOIs	https://doi.org/10.1093/jtm/taac036
State	Published - 1 Aug 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

B.1.617.2
BBIBP-CorV
BNT162b2
COVID-19
Delta
SARS-CoV-2
vaccine effectiveness

Access to Document

10.1093/jtm/taac036

Cite this

Mousa, M., Albreiki, M., Alshehhi, F., AlShamsi, S., Al Marzouqi, N., Alawadi, T., Alrand, H., Alsafar, H., & Fikri, A. (2022). Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE. Journal of Travel Medicine, 29(6), Article taac036. https://doi.org/10.1093/jtm/taac036

@article{904b2f456c754ccb8c46686180ecd2ad,

title = "Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE",

keywords = "B.1.617.2, BBIBP-CorV, BNT162b2, COVID-19, Delta, SARS-CoV-2, vaccine effectiveness",

author = "Mira Mousa and Mohammed Albreiki and Fatima Alshehhi and Safiya AlShamsi and \{Al Marzouqi\}, Nada and Tayba Alawadi and Hussain Alrand and Habiba Alsafar and Asma Fikri",

year = "2022",

month = aug,

day = "1",

doi = "10.1093/jtm/taac036",

language = "English",

volume = "29",

journal = "Journal of Travel Medicine",

issn = "1195-1982",

publisher = "Oxford University Press",

number = "6",

}

Mousa, M , Albreiki, M, Alshehhi, F, AlShamsi, S, Al Marzouqi, N , Alawadi, T , Alrand, H , Alsafar, H & Fikri, A 2022, 'Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE', Journal of Travel Medicine, vol. 29, no. 6, taac036. https://doi.org/10.1093/jtm/taac036

Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE. / Mousa, Mira ; Albreiki, Mohammed; Alshehhi, Fatima et al.
In: Journal of Travel Medicine, Vol. 29, No. 6, taac036, 01.08.2022.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

AU - Mousa, Mira

AU - Albreiki, Mohammed

AU - Alshehhi, Fatima

AU - AlShamsi, Safiya

AU - Al Marzouqi, Nada

AU - Alawadi, Tayba

AU - Alrand, Hussain

AU - Alsafar, Habiba

AU - Fikri, Asma

PY - 2022/8/1

Y1 - 2022/8/1

KW - B.1.617.2

KW - BBIBP-CorV

KW - BNT162b2

KW - COVID-19

KW - Delta

KW - SARS-CoV-2

KW - vaccine effectiveness

UR - https://www.scopus.com/pages/publications/85138458512

U2 - 10.1093/jtm/taac036

DO - 10.1093/jtm/taac036

M3 - Letter

C2 - 35244687

AN - SCOPUS:85138458512

SN - 1195-1982

VL - 29

JO - Journal of Travel Medicine

JF - Journal of Travel Medicine

IS - 6

M1 - taac036

ER -

Similar effectiveness of the inactivated vaccine BBIBP-CorV (Sinopharm) and the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19 related hospitalizations during the Delta outbreak in the UAE

UN SDGs

Keywords

Access to Document

Other files and links

Cite this